{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 459526771
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = Fab'
| source = o
| target = [[CD22]]
<!-- Clinical data -->
| tradename = LymphoScan
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category = 
| legal_AU = 
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 
<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 158318-63-9
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula = 
| molecular_weight = 
}}
'''Bectumomab''' (marketed under the trade name '''LymphoScan''') is a [[mouse]] [[monoclonal antibody]] labelled with the radioactive isotope [[technetium-99m]]. It is used to detect [[non-Hodgkin's lymphoma]].<ref>[http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list75.pdf WHO Drug Information]</ref><ref>{{cite journal|year=2002|title=Radioimmunoscintigraphy (RIS) with Bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL)|journal=Cancer biotherapy & radiopharmaceuticals|volume=17|issue=6|pages=689â€“697|issn=1084-9785|url=http://cat.inist.fr/?aModele=afficheN&cpsidt=14422885|doi=10.1089/108497802320970307|pmid=12537673|last1=Lamonica|first1=D.|last2=Czuczman|first2=M.|last3=Nabi|first3=H.|last4=Klippenstein|first4=D.|last5=Grossman|first5=Z.}}</ref>

==References==
{{reflist}}

{{Monoclonals for tumors}}

[[Category:Monoclonal antibodies for tumors]]
[[Category:Technetium compounds]]
[[Category:Technetium-99m]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}